Mutations in FH and SDH in these cancer cells cause an accumulation of metabolites which leak out of the mitochondrial matrix and inhibit prolyl hydralase (PHD) enzymes, leading to apoptotic resistance and hypoxia signaling (even under oxygen-stable conditions) (King et al., 2006). The gene discussed is FH; the disease is cancer.